Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Ostin Technology Group Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Kadant Acquires KWS Manufacturing Company
-
Fordham University Gabelli School of Business Global Healthcare Innovation Management Center to Host – AI and Healthcare: Beyond the Hype
-
Brompton Tech Leaders Income ETF Announces Increased Distributions
-
Brookfield Residential 2023 Fourth Quarter and Year End Results Conference Call Notice
-
Guggenheim First Quarter 2024 High-Yield and Bank Loan Outlook: Higher-Quality Leveraged Credit Should Benefit from Fed Easing Cycle
-
Raymond James Financial Reports Fiscal First Quarter of 2024 Results
-
Brompton Flaherty & Crumrine Investment Grade Preferred ETF Announces Increased Distributions
-
SL Green Realty Corp. Reports Fourth Quarter 2023 EPS of ($2.45) per Share; and FFO of $0.72 per Share After Non-Recurring Charges
-
Hanover Bancorp, Inc. Reports Earnings for the Fourth Calendar Quarter highlighted by Increased Net Income and Net Interest Income and Strong Non-interest Income
-
Uniti Group Inc. Announces Tax Reporting Information for 2023 Distributions
-
Origin Bancorp, Inc. Reports Earnings For Fourth Quarter and 2023 Full Year
-
Crown Castle Reports Fourth Quarter 2023 and Full Year 2023 Results, Maintains Outlook for Full Year 2024
-
Eagle Bancorp, Inc. Announces Net Income For Fourth Quarter 2023 Of $20.2 Million Or $0.67 Per Diluted Share
-
Univest Financial Corporation Reports Fourth Quarter and 2023 Results
-
Ryman Hospitality Properties, Inc. Announces 2023 Tax Classification of Shareholder Dividend Distributions
-
Origin Bancorp, Inc. Announces Declaration of Quarterly Cash Dividend
-
Plexus Announces Fiscal First Quarter Financial Results
-
Horizon Aircraft to Ring the Nasdaq Closing Bell on Thursday, January 25, 2024 to Commemorate Public Listing
-
Matthews International Declares Quarterly Dividend
-
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
-
John B. Sanfilippo & Son, Inc. 2nd Quarter Fiscal Year 2024 Operating Results Conference Call
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
John B. Sanfilippo & Son, Inc. 2nd Quarter Fiscal Year 2024 Operating Results Conference Call
-
Brookline Bancorp Announces Fourth Quarter Results
-
Tourmaline Bio Announces Proposed Public Offering of Common Stock
-
Udemy to Announce Fourth Quarter and Full Year 2023 Results on February 14
-
Horizon Bancorp, Inc. Announces Fourth Quarter and Full Year 2023 Results, Successfully Executes Balance Sheet Restructuring for Future Earnings Growth
-
Brookline Bancorp, Inc. Announces 2024 Virtual Annual Meeting Information
-
AMSC Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Business Outlook
-
Advanced Emissions Solutions Signs Contract for Construction of Granular Activated Carbon Expansion at Red River Plant with Wieland
-
Autoscope Technologies Corporation Announces 2024 Annual Meeting of Shareholders
-
Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq
-
FNCB Bancorp, Inc. Declares First Quarter 2024 Dividend
-
ACV to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
-
Ethan Allen Reports Fiscal 2024 Second Quarter Results Highlighted by Strong Margins and Robust Balance Sheet; Lower Sales Reflect Post Pandemic Economy
-
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
-
ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo
-
Five Below Appoints Karen Bowman to Board of Directors
-
Concentrix Reports Fiscal 2023 Fourth Quarter and Full Year Results
-
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date January 12, 2024
-
Magnite to Announce Fourth Quarter 2023 Financial Results on February 28, 2024
-
Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis
-
23andMe to Report FY2024 Third Quarter Financial Results
-
Credit Acceptance Announces Timing of Fourth Quarter 2023 Earnings Release and Webcast
-
Preferred Bank Reports Quarterly and Annual Results
-
CSX Corp. Announces Fourth Quarter and Full Year 2023 Results
-
Heartland Financial USA, Inc. (“HTLF”) Announces Common Stock and Series E Preferred Stock Dividends
-
Brompton Enhanced Multi-Asset Income ETF Announces Increased Distributions
